Current capabilities and limitations for the diagnosis of etiology of ocular tuberculosis: a review
DOI:
https://doi.org/10.31288/Ukr.j.ophthalmol.202656976Keywords:
ocular tuberculosis, uveitis, Mycobacterium tuberculosis, PCR, interferon-gamma release assays, tuberculin testAbstract
Ocular tuberculosis (OTB) remains one of the most diagnostically challenging extrapulmonary forms of tuberculosis in terms of determining the etiology. The paucibacillary nature of the disease, small quantity of intraocular samples, and pathogenetic heterogeneity significantly complicate the direct confirmation of Mycobacterium tuberculosis (MBT) in ocular tissue and fluid samples. This paper reviewed current capabilities and limitations for the diagnosis of etiology of OTB. Molecular gene methods for direct detection of MBT, including polymerase chain reaction (PCR), automated molecular platforms and studies on cell-free DNA analysis, were considered. Despite advances in these methods, they still do not have enough sensitivity for negative results to rule out OTB. Special attention was given to the methods allowing indirect confirmation of MBT infection, tuberculin skin test (TST) and interferon-gamma release analysis (IGRA), particularly, QuantiFERON. A positive IGRA result indicates the presence of a specific immune response to MBT, but does not localize the infectious process or independently confirm a causal relationship between MBT infection and intraocular inflammation. The absence of an independent and sufficiently sensitive reference standard for OTB detection is a major issue in the assessment of diagnostic accuracy of current OTB detection methods. Future research should be aimed not only at increasing the sensitivity of direct diagnostic methods, but also focused on the search for, and independent validation of markers that will allow differentiation between etiologically MBT-related intraocular inflammation from concomitant latent infection.
References
Ludi Z, Sule AA, Samy RP, et al. Diagnosis and biomarkers for ocular tuberculosis: From the present into the future. Theranostics. 2023;13(7):2088-2113. https://doi.org/10.7150/thno.81488
Konana VK, Babu K. Current concepts in the diagnosis of ocular tuberculosis: A narrative review. Taiwan J Ophthalmol. 2025;15(2):203-211. https://doi.org/10.4103/tjo.TJO-D-24-00115
Alabed ST, Finkel D. Ocular TB as the only manifestation of TB: diagnostic uncertainty and treatment thresholds. Int Ophthalmol. 2026;46(1):268. https://doi.org/10.1007/s10792-026-04134-3
Tungsattayathitthan U, Boonsopon S, Tesavibul N, et al. Interferon-gamma release assays in tuberculous uveitis: a comprehensive review. Int J Ophthalmol. 2022;15(9):1520-1528. https://doi.org/10.18240/ijo.2022.09.16
Putera I, Ten Berge JCEM, Thiadens AAHJ, et al. Clinical Features and Predictors of Treatment Outcome in Patients with Ocular Tuberculosis from the Netherlands and Indonesia: The OculaR TB in Low versus High Endemic Countries (ORTEC) Study. Ocul Immunol Inflamm. 2025;33(1):86-97.https://doi.org/10.1080/09273948.2024.2359614
Basu S, Elkington P, Rao NA. Pathogenesis of ocular tuberculosis: New observations and future directions. Tuberculosis (Edinb). 2020;124:101961. https://doi.org/10.1016/j.tube.2020.101961
Agrawal R, Testi I, Rousselot A, et al. Insights into the molecular pathogenesis of ocular tuberculosis. Tuberculosis (Edinb). 2021;126:102018. https://doi.org/10.1016/j.tube.2020.102018
Putera I, Widodo E, Riasanti M, et al. Ocular tuberculosis with Mycobacterium tuberculosis DNA presence in ocular fluid: will post-COVID era bring a difference? Eye (Lond). 2024;38(15):3027-3029.https://doi.org/10.1038/s41433-024-03200-3
Balne PK, Modi RR, Choudhury N, et al. Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis. J Ophthalmic Inflamm Infect. 2014;4(1):10.https://doi.org/10.1186/1869-5760-4-10
Barik MR, Rath S, Modi R, et al. Normalised quantitative polymerase chain reaction for diagnosis of tuberculosis-associated uveitis. Tuberculosis (Edinb). 2018;110:30-35. https://doi.org/10.1016/j.tube.2018.03.005
Sharma K, Sharma M, Ayyadurai N, et al. Comparative Evaluation of GeneXpert MTB/RIF Ultra and GeneXpert MTB/RIF for Detecting Tuberculosis and Identifying Rifampicin Resistance in Pars Plana Vitrectomy Samples of Patients with Ocular Tuberculosis. Ocul Immunol Inflamm. 2023;31(5):914-920. https://doi.org/10.1080/09273948.2022.2064880
Sharma K, Sharma M, Ayyadurai N, et al. Evaluating Truenat Assay for the Diagnosis of Ocular Tuberculosis and Detection of Drug Resistance. Ocul Immunol Inflamm. 2024;32(6):976-982. https://doi.org/10.1080/09273948.2023.2170888
Sharma K, Sharma M, Joshi H, et al. Evaluation of Mycobacterium Tuberculosis Derived Cell-Free DNA-Based Multi-Targeted Real-Time PCR from Vitreous Fluid (VF) Samples to Diagnose Ocular Tuberculosis. Ocul Immunol Inflamm. 2025;33(9):1907-1912. https://doi.org/10.1080/09273948.2025.2532820
Agarwal A, Agrawal R, Gunasekaran DV, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends. Ocul Immunol Inflamm. 2019;27(3):465-473. https://doi.org/10.1080/09273948.2017.1406529
La Distia Nora R, Putera I, Khalisha DF, et al. The diagnostic value of polymerase chain reaction for ocular tuberculosis diagnosis in relation to antitubercular therapy response: a meta-analysis. Int J Infect Dis. 2021;110:394-402. https://doi.org/10.1016/j.ijid.2021.07.075
Fernández-Zamora Y, Finamor LP, Silva LMP, et al. Role of Interferon-Gamma Release Assay for the Diagnosis and Clinical Follow up in Ocular Tuberculosis. Ocul Immunol Inflamm. 2023;31(2):304-311.https://doi.org/10.1080/09273948.2022.2027459
Ang M, Wong WL, Li X, et al. Interferon γ release assay for the diagnosis of uveitis associated with tuberculosis: a Bayesian evaluation in the absence of a gold standard. Br J Ophthalmol. 2013;97(8):1062-1067.https://doi.org/10.1136/bjophthalmol-2012-302199
Xia J, Palestine AG, Reddy AK. Diagnostic Utility of QuantiFERON-Gold Testing in Patients with Ocular Inflammation in a Low-Endemic Tuberculosis Region. Am J Ophthalmol. 2024;264:1-7.https://doi.org/10.1016/j.ajo.2024.03.010
Putera I, Rothova A, La Distia Nora R. Comparison of uveitis manifestations in patients with active systemic tuberculosis and those with positive interferon-gamma release assay without active disease. Eye (Lond). 2025;39(9):1772-1780. https://doi.org/10.1038/s41433-025-03751-z
La Distia Nora R, Putera I, Riasanti M, et al. Antitubercular therapy for uveitis of undetermined cause with positive interferon-gamma release assay: a single-blind, single-centre, phase 2 randomised controlled trial. EClinicalMedicine. 2025;88:103511. https://doi.org/10.1016/j.eclinm.2025.103511
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Вікторія Колесніченко, Олександра Дорохова, Олександра Зборовська

This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.







